Recently, Zhao et al. [11] performed step-to-multiple logistic regression analysis on 1000 samples and obtained the NAFLD index (NFI), which includes ALT/AST and TG, as a clinical scoring tool for predicting NAFLD. Accordingly, we compared the predictive value of UHR for NAFLD onset in non-obese adults to other indicators recently proposed in the literature [34–38]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.